Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$311.13
-0.2%
$313.14
$176.34
$413.20
$23.41B1.65736,758 shs448,593 shs
Enovis Co. stock logo
ENOV
Enovis
$55.64
+0.3%
$60.10
$43.04
$66.14
$3.05B1.97455,621 shs73,301 shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$24.49
-1.3%
$26.20
$21.52
$33.08
$10.71B0.73969,621 shs613,623 shs
STERIS plc stock logo
STE
STERIS
$203.60
-1.2%
$222.85
$180.54
$254.00
$20.12B0.79459,275 shs109,189 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+3.68%+2.22%-2.36%+21.32%-14.10%
Enovis Co. stock logo
ENOV
Enovis
-0.04%-1.82%-7.87%-5.53%-4.74%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
+1.81%+4.25%-5.34%-9.52%-22.23%
STERIS plc stock logo
STE
STERIS
+2.51%+3.52%-10.07%-4.14%+9.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.8134 of 5 stars
3.24.00.03.82.42.53.1
Enovis Co. stock logo
ENOV
Enovis
2.7356 of 5 stars
3.51.00.00.01.81.72.5
Smith & Nephew plc stock logo
SNN
Smith & Nephew
3.1423 of 5 stars
0.05.02.50.03.70.01.9
STERIS plc stock logo
STE
STERIS
4.5436 of 5 stars
2.32.04.23.82.71.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.44
Hold$344.4510.71% Upside
Enovis Co. stock logo
ENOV
Enovis
3.00
Buy$75.4335.57% Upside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.40
HoldN/AN/A
STERIS plc stock logo
STE
STERIS
2.50
Moderate Buy$239.6017.68% Upside

Current Analyst Ratings

Latest SNN, STE, ALGN, and ENOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$350.00 ➝ $400.00
4/15/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$280.00 ➝ $320.00
4/12/2024
STERIS plc stock logo
STE
STERIS
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/10/2024
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$82.00
3/15/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$340.00 ➝ $350.00
3/14/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$335.00 ➝ $355.00
2/26/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$310.00
2/23/2024
Enovis Co. stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$73.00 ➝ $79.00
2/23/2024
Enovis Co. stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$73.00 ➝ $75.00
2/23/2024
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$73.00 ➝ $82.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$3.86B6.06$8.74 per share35.58$47.40 per share6.56
Enovis Co. stock logo
ENOV
Enovis
$1.71B1.79$6.41 per share8.68$62.66 per share0.89
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.55B1.93$3.23 per share7.58$11.94 per share2.05
STERIS plc stock logo
STE
STERIS
$4.96B4.06$19.12 per share10.65$61.31 per share3.32

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$445.05M$5.8253.4634.765.3911.52%13.88%8.26%4/24/2024 (Confirmed)
Enovis Co. stock logo
ENOV
Enovis
-$33.26M-$0.61N/A18.24N/A-1.95%3.84%2.99%5/2/2024 (Confirmed)
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263MN/A0.0011.771.31N/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$107.03M$5.7135.6621.39N/A10.48%13.67%7.68%5/8/2024 (Estimated)

Latest SNN, STE, ALGN, and ENOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Enovis Co. stock logo
ENOV
Enovis
$0.50N/A-$0.50N/AN/AN/A  
4/24/2024N/A
Align Technology, Inc. stock logo
ALGN
Align Technology
$1.9750$1.97-$0.0050N/AN/AN/A  
2/22/202412/31/2023
Enovis Co. stock logo
ENOV
Enovis
$0.76$0.79+$0.03$1.53$444.34 million$455.00 million      
2/7/2024Q3 24
STERIS plc stock logo
STE
STERIS
$2.17$2.22+$0.05$3.02$1.35 billion$1.40 billion    
1/31/2024Q4 2023
Align Technology, Inc. stock logo
ALGN
Align Technology
$1.78$1.91+$0.13$2.18$928.57 million$956.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Enovis Co. stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.903.67%N/AN/A1 Years
STERIS plc stock logo
STE
STERIS
$2.081.02%+8.74%36.43%19 Years

Latest SNN, STE, ALGN, and ENOV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2024
Smith & Nephew plc stock logo
SNN
Smith & Nephew
semi-annual$0.46202.8%4/1/20244/2/20245/22/2024
1/30/2024
STERIS plc stock logo
STE
STERIS
Quarterly$0.520.95%2/22/20242/23/20243/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.18
1.04
Enovis Co. stock logo
ENOV
Enovis
0.14
2.43
1.16
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.44
1.77
0.72
STERIS plc stock logo
STE
STERIS
0.50
2.43
1.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Enovis Co. stock logo
ENOV
Enovis
98.45%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%
STERIS plc stock logo
STE
STERIS
94.69%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.72%
Enovis Co. stock logo
ENOV
Enovis
2.40%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
STERIS plc stock logo
STE
STERIS
0.95%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
21,61075.25 million74.71 millionOptionable
Enovis Co. stock logo
ENOV
Enovis
6,55054.84 million53.52 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
18,452437.17 million432.80 millionOptionable
STERIS plc stock logo
STE
STERIS
17,10098.81 million97.88 millionOptionable

SNN, STE, ALGN, and ENOV Headlines

SourceHeadline
Jennison Associates LLC Has $58.93 Million Stake in STERIS plc (NYSE:STE)Jennison Associates LLC Has $58.93 Million Stake in STERIS plc (NYSE:STE)
marketbeat.com - April 24 at 7:19 AM
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy FacilitiesINTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities
pharmtech.com - April 22 at 5:48 PM
Taking a Deeper Look at Sterile Powder Transfer in Aseptic Fill/Finish of Parenterals (INTERPHEX 2024)Taking a Deeper Look at Sterile Powder Transfer in Aseptic Fill/Finish of Parenterals (INTERPHEX 2024)
pharmtech.com - April 22 at 5:48 PM
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
zacks.com - April 22 at 3:16 PM
abrdn plc Has $55.19 Million Stock Holdings in STERIS plc (NYSE:STE)abrdn plc Has $55.19 Million Stock Holdings in STERIS plc (NYSE:STE)
marketbeat.com - April 22 at 7:20 AM
Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in STERIS plc (NYSE:STE)Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in STERIS plc (NYSE:STE)
marketbeat.com - April 21 at 5:43 AM
Groundbreaking hydrogel can remove microplastics from waterGroundbreaking hydrogel can remove microplastics from water
bgr.com - April 20 at 6:24 PM
This is your last chance to see the ‘devil comet’ until 2095This is your last chance to see the ‘devil comet’ until 2095
msn.com - April 20 at 6:24 PM
International Assets Investment Management LLC Acquires Shares of 10,113 STERIS plc (NYSE:STE)International Assets Investment Management LLC Acquires Shares of 10,113 STERIS plc (NYSE:STE)
marketbeat.com - April 20 at 4:42 AM
STERIS plc (NYSE:STE) Receives Consensus Rating of "Moderate Buy" from BrokeragesSTERIS plc (NYSE:STE) Receives Consensus Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - April 18 at 2:36 AM
Strs Ohio Acquires 8,518 Shares of STERIS plc (NYSE:STE)Strs Ohio Acquires 8,518 Shares of STERIS plc (NYSE:STE)
marketbeat.com - April 17 at 6:36 AM
Is The Market Rewarding STERIS plc (NYSE:STE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?Is The Market Rewarding STERIS plc (NYSE:STE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
finance.yahoo.com - April 16 at 7:22 PM
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
zacks.com - April 15 at 12:21 PM
Cullen Investment Group LTD. Invests $1.35 Million in STERIS plc (NYSE:STE)Cullen Investment Group LTD. Invests $1.35 Million in STERIS plc (NYSE:STE)
marketbeat.com - April 15 at 11:27 AM
Steris: Moving On, Losing Its TeethSteris: Moving On, Losing Its Teeth
seekingalpha.com - April 14 at 7:00 AM
STERIS plc (NYSE:STE) Holdings Increased by Cerity Partners LLCSTERIS plc (NYSE:STE) Holdings Increased by Cerity Partners LLC
marketbeat.com - April 14 at 6:19 AM
STERIS (NYSE:STE) Receives Hold Rating from Needham & Company LLCSTERIS (NYSE:STE) Receives Hold Rating from Needham & Company LLC
americanbankingnews.com - April 14 at 2:54 AM
WCM Investment Management LLC Lowers Position in STERIS plc (NYSE:STE)WCM Investment Management LLC Lowers Position in STERIS plc (NYSE:STE)
marketbeat.com - April 13 at 1:42 PM
STERISs (STE) Hold Rating Reaffirmed at Needham & Company LLCSTERIS's (STE) Hold Rating Reaffirmed at Needham & Company LLC
marketbeat.com - April 12 at 8:23 AM
Illinois awards first abortion training grantsIllinois awards first abortion training grants
chicagobusiness.com - April 12 at 1:13 AM
As measles worries rise, schools are asked to draw up lists of unvaxxed studentsAs measles worries rise, schools are asked to draw up lists of unvaxxed students
chicagobusiness.com - April 12 at 1:13 AM
Peak Rock Capital to buy Chicago manufacturer for $787.5 millionPeak Rock Capital to buy Chicago manufacturer for $787.5 million
bizjournals.com - April 11 at 8:08 PM
Steris to sell dental segment for nearly $800 millionSteris to sell dental segment for nearly $800 million
crainscleveland.com - April 11 at 3:01 PM
Peak Rock Capital takes a bite out of Steris with $787M dental business dealPeak Rock Capital takes a bite out of Steris with $787M dental business deal
fiercebiotech.com - April 11 at 3:01 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Align Technology logo

Align Technology

NASDAQ:ALGN
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Enovis logo

Enovis

NYSE:ENOV
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Smith & Nephew logo

Smith & Nephew

NYSE:SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
STERIS logo

STERIS

NYSE:STE
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.